On a final note, GDE2 deficiency leads to progressive neurodegeneration in mice with motor neuron pathologies analogous to those in human disease, while it strongly correlates with poor clinical outcome in neuroblastoma (Cave et al., 2017; Matas-Rico et al., 2016). Here, GDPD5 is linked to neuroblastoma.